Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
80.95
+0.19 (0.24%)
Nov 7, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $583.2 million as of November 7, 2025. Its market cap has increased by 3,478.04% in one year.
Market Cap
583.20M
Enterprise Value
530.06M
1-Year Change
3,478.04%
Ranking
Category
Stock Price
$80.95
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $583.20M, an increase of 111.18%. That is a compound annual growth rate of 13.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 583.20M | 334.68% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | 70.09M | -59.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |